ReportingMassachusetts
Waltham's Sionna cuts about 46 percent of staff after cystic fibrosis trial miss

The biotech has not said how many jobs that is. It is dropping an add-on drug and shifting to a different combination.
Published
Loading coverage...
Coverage of Sionna from Six State Signal.

The biotech has not said how many jobs that is. It is dropping an add-on drug and shifting to a different combination.